Franz B Humer Allogene Therapeutics, Inc. (ALLO) insider trading activity

ALLO Quotes by TradingView

Franz B Humer is Director of Allogene Therapeutics, Inc.. Currently has a direct ownership of 307,507 shares of ALLO, which is worth approximately $673,440. The most recent transaction as insider was on Dec 05, 2024, when has been sold 9,221 shares (Common Stock) at a price of $2.16 per share, resulting in proceeds of $19,917. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 308K
2.91% 3M change
15.41% 12M change
Total Value Held $673,440

Franz B Humer Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 05 2024
SELL
Open market or private sale
$19,917 $2.16 p/Share
9,221 Reduced 2.91%
307,507 Common Stock
Jun 05 2024
BUY
Grant, award, or other acquisition
-
61,475 Added 16.25%
316,728 Common Stock
May 30 2024
SELL
Open market or private sale
$26,208 $2.34 p/Share
11,200 Reduced 4.2%
255,253 Common Stock
Jun 13 2023
BUY
Grant, award, or other acquisition
-
74,561 Added 21.86%
266,453 Common Stock
Jun 15 2022
BUY
Grant, award, or other acquisition
-
44,178 Added 18.71%
191,892 Common Stock
Jun 10 2021
BUY
Grant, award, or other acquisition
-
16,498 Added 10.05%
147,714 Common Stock
FBH

Franz B Humer

Director
South San Francisco, CA

Track Institutional and Insider Activities on ALLO

Follow Allogene Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALLO shares.

Notify only if

Insider Trading

Get notified when an Allogene Therapeutics, Inc. insider buys or sells ALLO shares.

Notify only if

News

Receive news related to Allogene Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ALLO